David R Hill

USPTO Granted Patents = 15 (Patent Applications = 6)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 222(Granted Patents)

Location History:

Trinidad, CO (US) (2015 - 2018)
Gurnee, IL (US) (1998 - 2019)

Company Filing History:

7 out of 4,179

Abbott Laboratories Corporation

Reservoir Management Services, LLC

patents

Years Active: 1998-2019

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10442792 - Synthetic route to anti-viral agents (2019-10-15),

2. 10421712 - Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof (2019-09-24),

3. 10316338 - Enzymatic process for the preparation of (1S,2R)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic acid (2019-06-11),

4. 10087743 - Fluid level determination apparatus and method of determining a fluid level in a hydrocarbon well (2018-10-02),

5. 10077256 - Synthetic route to anti-viral agents (2018-09-18),

6. 9809576 - Synthetic route to anti-viral agents (2017-11-07),

7. 9809534 - Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof (2017-11-07),

8. 9127536 - Tool for use in well monitoring (2015-09-08),

9. 8168784 - Processes to make apoptosis promoters (2012-05-01),

10. RE39531 - 9-hydrazone and 9-azine erythromycin derivatives and a process for making the same (2007-03-26),

11. 6441189 - Process for the preparation of matrix metalloproteinase inhibitors (2002-08-27),

12. 6437106 - Process for preparing 6-o-substituted erythromycin derivatives (2002-08-20),

13. 6350902 - Process for the selective N-formylation of N-hydroxylamines (2002-02-26),

14. 5929219 - 9-hydrazone and 9-azine erythromycin derivatives and a process of making (1999-07-27),

15. 5760216 - Use of synthetic metalloporphyrins for preparation and prediction of (1998-06-02),

Title: The Innovative Mind of David R. Hill

Introduction

David R. Hill, an esteemed inventor based in Gurnee, Illinois, has made significant contributions to the field of pharmaceuticals through his inventive prowess. With a remarkable portfolio of 15 patents, Hill continues to push the boundaries of scientific research, particularly in the development of anti-viral agents.

Latest Patents

Among his latest innovations is a patent titled "Synthetic route to anti-viral agents," which presents methods for synthesizing a viral protease inhibitor with high yield, effectively avoiding the use of expensive catalysts and difficult reaction conditions. Another notable patent, "Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof," introduces methods for synthesizing compounds in an asymmetric or enantioenriched manner, which serve as useful intermediates in the creation of viral protease inhibitors.

Career Highlights

David R. Hill has had an impactful career, working with renowned companies such as Abbott Laboratories and AbbVie Inc. His work in these institutions has contributed significantly to advancements in antiviral research, showcasing his commitment to improving public health through innovation.

Collaborations

Hill has collaborated with notable professionals, including Jianzhang Mei and Michael J. Abrahamson, which reflects his capacity for teamwork and shared innovation. These collaborations have further enriched his research and development endeavors in the pharmaceutical landscape.

Conclusion

David R. Hill exemplifies the spirit of innovation in the scientific community. With a strong foundation in research and a clear focus on addressing global health challenges, his contributions through patents not only enhance our understanding of antiviral treatments but also pave the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.